Rhein-based necrosis-avid MRI contrast agents for early evaluation of tumor response to microwave ablation therapy.
Tianze WuJian ZhangQiaomei JinMeng GaoDongjian ZhangLibang ZhangYuanbo FengYicheng NiZhiqi YinPublished in: Magnetic resonance in medicine (2019)
GdL2 appears to be a promising NACA for the tumor response assessment after thermal ablation therapies.